Pancreatic cancer remains one of the deadliest cancers with a five-year survival rate of just six percent and no early detection tools or effective treatments.
Thanks to the Recalcitrant Cancer Research Act, a new law enacted in January, there is hope for those touched by this disease. I would like to thank Senator Lautenberg and Senator Menendez for supporting this historic legislation, which requires the National Cancer Institute (NCI) to evaluate its current efforts in researching pancreatic cancer and focus on ways to improve outcomes for patients.
Due to sequestration, however, federal funding for medical and cancer research has been cut, and the progress we have made is now being threatened. Without adequate NCI funding, it will be difficult to leverage the opportunities that develop as a result of the passage of the Recalcitrant Cancer Research Act.
On June 18, I will be joining thousands of advocates across the country for the Pancreatic Cancer Action Network’s (www.pancan.org) National Call-in to Congress to urge them to save medical research that saves lives. This disease has had a devastating impact on my life, but with Congress’ help, we will be able to develop the tools and treatments so desperately needed to give hope to future generations.
Todd Cohen, Edison
Connect with NJTODAY.NET
Join NJTODAY.NET's free Email List to receive occasional updates delivered right to your email address!